Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study

Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study

The differences in prognoses or progression patterns between T4b non-N4 and non-T4b N4 esophageal squamous cell carcinoma post chemoradiotherapy (CRT) is unclear. This study compared the outcomes of CRT for stage IVa esophageal squamous cell carcinoma according to T/N factors. We retrospectively ide...

Full description

Bibliographic Details
Main Authors:	Yuki Wada, Akira Anbai, Noriko Takagi, Satoshi Kumagai, Eriko Okuyama, Hiroshi Nanjo, Yusuke Sato, Satoru Motoyama, Manabu Hashimoto
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Cancers
Subjects:	esophageal squamous cell carcinoma definitive chemoradiation therapy external beam radiation therapy locally advanced esophageal cancer
Online Access:	https://www.mdpi.com/2072-6694/13/1/8

Similar Items

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
by: Thomas Matoska, et al.
Published: (2023-04-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)

Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis
by: Styliani Mantziari, et al.
Published: (2021-04-01)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
by: Yusuke Sato, et al.
Published: (2021-02-01)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
by: Yu-Chieh Ho, et al.
Published: (2023-09-01)

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
by: Rishi Jain, et al.
Published: (2020-10-01)

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
by: Franziska Walter, et al.
Published: (2018-05-01)

Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
by: Wei-Chung Chen, et al.
Published: (2022-08-01)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
by: R.S.A. Goedegebuure, et al.
Published: (2021-01-01)

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
by: Han Tang, et al.
Published: (2017-06-01)

Immunotherapy Plus Chemoradiation Improves Overall Survival in Stage IV Esophageal Cancer: A Cohort Study
by: Saber Amin, et al.
Published: (2024-01-01)

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers
by: Noah Kastelowitz, et al.
Published: (2021-03-01)

A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma
by: Gregory Vlacich, et al.
Published: (2021-09-01)

Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database
by: Xiaojie Xia, et al.
Published: (2021-09-01)

Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy
by: Takahiro Mori, et al.
Published: (2021-01-01)

Prognostic significance and postoperative chemoradiotherapy guiding value of mean platelet volume for locally advanced esophageal squamous cell carcinoma patients
by: Wei Zhang, et al.
Published: (2023-04-01)

Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome
by: Ivane Kiladze, et al.
Published: (2023-03-01)

Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis
by: Philipp Linde, et al.
Published: (2022-11-01)

Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
by: Chia-Chin Li, et al.
Published: (2021-04-01)

The Impact of Radiation to Epicardial Adipose Tissue on Prognosis of Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Esophagectomy
by: Hung-Chi Tai, et al.
Published: (2021-04-01)

Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy
by: Yue Li, et al.
Published: (2021-02-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective
by: Lye-Yeng Wong, MD, et al.
Published: (2023-06-01)

Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation
by: Hu Qiu, et al.
Published: (2021-09-01)

Multimodal Treatment Strategies to Improve the Prognosis of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Narrative Review
by: Tadashi Higuchi, et al.
Published: (2022-12-01)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
by: Honghai Dai, et al.
Published: (2020-03-01)

Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
by: Chu-Pin Pai, et al.
Published: (2023-11-01)

FOXO transcriptional activity is associated with response to chemoradiation in EAC
by: A. Creemers, et al.
Published: (2022-04-01)

A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute
by: Jin-Ho Choi, et al.
Published: (2022-04-01)

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
by: Ming-Wei Ma, et al.
Published: (2018-08-01)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
by: Jae Kwang Yun, et al.
Published: (2022-10-01)

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
by: J. Ristau, et al.
Published: (2021-02-01)

Preoperative Chemoradiation versus Chemotherapy in Locally Advanced Resectable Esophageal Cancer: A Retrospective Study
by: Waseem Abbas, et al.
Published: (2022-07-01)

Editorial: Esophageal Stenosis in Esophageal Atresia and Chemical Burn: Update on an Unsolved Problem
by: S. Loff
Published: (2022-11-01)

Aging‐related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer
by: Yong‐Chun Zhou, et al.
Published: (2018-05-01)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
by: Tian Zhang, et al.
Published: (2022-08-01)

Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas
by: Zhiqin Chen, et al.
Published: (2021-11-01)

The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients
by: Fatemeh Khanaki, et al.
Published: (2022-12-01)

SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes
by: I-Ying Kuo, et al.
Published: (2019-02-01)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
by: Tania Triantafyllou, et al.
Published: (2020-07-01)